Quarterly ResultMay 8, 2026, 08:56 AM
Progyny Q1 Net Income +60.9% to $24.2M; EPS $0.29; $117.7M Share Buyback
AI Summary
Progyny, Inc. reported strong financial performance for the first quarter of 2026, with net income significantly increasing by 60.9% to $24.2 million and diluted earnings per share rising by 70.6% to $0.29. The company, which specializes in fertility, family building, and women's health benefits solutions, also saw a modest revenue increase of 1.4% to $328.5 million. Additionally, Progyny repurchased $117.7 million of its common stock during the quarter.
Key Highlights
- Net income increased 60.9% to $24.2 million for Q1 2026.
- Diluted EPS rose 70.6% to $0.29 for Q1 2026.
- Revenue grew 1.4% to $328.5 million for Q1 2026.
- Gross profit increased 9.6% to $83.1 million for Q1 2026.
- Income from operations surged 46.4% to $35.4 million for Q1 2026.
- Repurchased $117.7 million of common stock during Q1 2026.
- Cash and cash equivalents stood at $131.6 million as of March 31, 2026.
Price Impact
More from PGNY